PT  - JOURNAL ARTICLE
AU  - Khan, Md. Nuruzzaman
AU  - Oldroyd, John C.
AU  - Chowdhury, Enayet K.
AU  - Hossain, Mohammad Bellal
AU  - Rana, Juwel
AU  - Renzetti, Stefano
AU  - Islam, Rakibul M.
TI  - Prevalence, awareness, treatment, and control of hypertension in Bangladesh: Findings from National Demographic and Health Survey, 2017-18
AID  - 10.1101/2021.04.09.21255237
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.04.09.21255237
4099  - http://medrxiv.org/content/early/2021/07/28/2021.04.09.21255237.short
4100  - http://medrxiv.org/content/early/2021/07/28/2021.04.09.21255237.full
AB  - Objective To estimate the age-standardised prevalence, awareness, treatment, and control of hypertension and to identify their risk factors in Bangladeshi adults using the Bangladesh Demographic and Health Survey (BDHS) 2017-18 data.Methods Data from 12, 904 adults aged 18-95 years old, median (IQR) = 36 years (26-50), available from the most recent nationally representative BDHS 2017-18 were used. Hypertension was defined as having systolic blood pressure ≥140 mmHg and/or a diastolic blood pressure ≥90 mmHg, and/or taking anti-hypertensive drugs to control blood pressure. Age-standardised prevalence of hypertension and management were estimated with direct standardisation. A multilevel mixed-effects Poisson regression model with a robust variance was used to identify risk factors associated with hypertension and its awareness, treatment, and control.Results The overall age-standardised prevalence of hypertension was 26.2% (95% CI, 25.5-26.9); (men: 23.5%, women: 28.9%). Among those with hypertension (n=3531), 36.7% were aware that they had the condition, and only 31.1% received anti-hypertensive medication. Among those treated for hypertension (n=1306), 43.6% had controlled hypertension. Factors independently associated with hypertension were increasing age, higher body mass index, being women, having diabetes, and residing in selected administrative divisions. A declining trend of hypertension control was observed with increasing age and low education.Conclusions Hypertension is highly prevalent (1 in 4) in Bangladeshi adults, while awareness, treatment, and control are low. Irrespective of the risks associated with hypertension and its management, awareness, treatment, and control programmes should be given high priority in reducing hypertension and improving hypertension control in Bangladesh.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNA as we used secondary survey dataFunding StatementThere was no funding availableAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The survey, including biomarker measurements, was approved by the institutional review board at ICF and the Bangladesh Medical Research Council. Informed consent was obtained from all participants.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData can be available on requestCVDCardiovascular diseaseLMICsLow- and middle-income countriesHICsHigh income countriesBDHSBangladesh Demographic and Health SurveyPSUPrimary sampling unitsSBSsystolic blood pressureDBPdiastolic blood pressureWHOWorld Health OrganizationPRPrevalence Ratio, 95%CI95% Confidence IntervalBMIBody Mass Index